Posts by: Somi Igbene

A model that considers changes in brain volume and serum neurofilament (sNfL) levels during the early stages of multiple sclerosis may help clinicians to determine an individual’s likely progression with relapsing ... Read more

October 11, 2021October 11, 2021

New PET Tracer May Better Capture Brain Inflammation in ALS

ALS News Today, COVID-19 News

An imaging agent developed by Ashvattha Therapeutics can accurately detect brain inflammation caused by microglia, immune cells that play a key role in neurological diseases such as amyotrophic lateral sclerosis ... Read more

October 5, 2021October 5, 2021

COVID-19 Stalling MS Research Into Rehabilitation, Quality of Life

COVID-19 News, Multiple Sclerosis News Today

The COVID-19 pandemic appears to be stalling research into rehabilitation and quality of life (QoL) for people with multiple sclerosis (MS) in many countries worldwide, a new observational study reports. ... Read more

October 1, 2021October 1, 2021

Advocacy Groups Invited to Try for Cytokinetics Communications Grants

ALS News Today

Cytokinetics is accepting applications from advocacy groups working in cardiovascular and neuromuscular diseases, including amyotrophic lateral sclerosis (ALS), for grants worth $20,000 each that will help them expand their communications and ... Read more

September 24, 2021September 24, 2021

Mount Sinai MS Experts Earn Hope Award

Multiple Sclerosis News Today

The National Multiple Sclerosis Society has granted its 2021 Hope Award to two multiple sclerosis (MS) experts at Mount Sinai Health System for their clinical ingenuity and significant research contributions ... Read more

September 24, 2021September 24, 2021

NIH Awards PathMaker $371K to Advance Neuromodulation Therapy

ALS News Today

PathMaker Neurosystems was awarded $371,000 from the National Institutes of Health (NIH) to advance its neuromodulation technology as a potential new, non-invasive treatment for amyotrophic lateral sclerosis (ALS). The Small ... Read more

September 22, 2021September 23, 2021

Stopping Fingolimod – Gilenya – for Pregnancy Raises Relapse Risk

Multiple Sclerosis News Today

Women with relapsing-remitting multiple sclerosis (MS) who suspend their use of fingolimod — sold as Gilenya, among others — to conceive or during the early stages of pregnancy have a ... Read more

September 20, 2021September 21, 2021

3 Factors Identified that May Predict Relapses Within 5 Years of AAV Diagnosis

ANCA Vasculitis News

A positive anti-proteinase 3 (PR3) ANCA test, lower serum creatinine levels, and cardiovascular involvement at diagnosis appear to raise the risk of relapse in people with ANCA-associated vasculitis (AAV), a ... Read more

September 13, 2021September 13, 2021

Health Status of Immigrants With MS Complex, Canadian Study Finds

Multiple Sclerosis News Today

A number of health conditions — including high blood pressure, migraines, schizophrenia, and rheumatoid arthritis — are more common among immigrants to Canada who have multiple sclerosis (MS) than those without ... Read more

September 8, 2021September 8, 2021

Health Canada to Review AMX0035 as ALS Treatment

ALS News Today

Health Canada has agreed to review Amylyx Pharmaceuticals‘ application seeking approval of AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS). “We are pleased that our submission has been accepted ... Read more

September 2, 2021September 2, 2021

FDA to Review ANI’s Request for Cortrophin Gel Use

Multiple Sclerosis News Today

The U.S. Food and Drug Administration (FDA) has agreed to review ANI Pharmaceuticals’ supplemental new drug application for the approval of Cortrophin Gel to treat people with multiple sclerosis (MS) ... Read more

August 27, 2021August 27, 2021

Researchers Seek Biomarkers to Predict ATYR1923’s Effectiveness

Sarcoidosis News

aTyr Pharma has announced a collaboration with The Ohio State University (OSU) to conduct cell culture studies seeking to identify potential biomarkers that can predict ATYR1923’s therapeutic effectiveness in people with ... Read more

August 26, 2021August 26, 2021

Pain, Fatigue, Anxiety Common in First Year After CIS/MS Diagnosis

COVID-19 News, Multiple Sclerosis News Today

People newly diagnosed with clinically isolated syndrome (CIS) or multiple sclerosis (MS) frequently experience pain, fatigue, depression, and anxiety in the first year after diagnosis, a new study finds. Fatigue ... Read more

August 25, 2021August 25, 2021

Ocrevus Reduces MS Relapse Risk, But Linked to More Hospitalizations

Multiple Sclerosis News Today

Ocrevus (ocrelizumab) reduces relapse risk and slows disability progression in multiple sclerosis (MS) but also is associated with higher hospitalization rates in older people with relapsing forms of the disease, a ... Read more

August 20, 2021August 20, 2021

Daily Breathing Exercises Seen to Slow Progression in IPF Patients

COVID-19 News, Pulmonary Fibrosis News

Simple breathing exercises as an add-on therapy can safely slow lung function decline and improve quality of life in people with mild to moderate idiopathic pulmonary fibrosis (IPF), a small ... Read more